Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis
-
- E. Matthews
- From MRC Centre for Neuromuscular Diseases (E.M., D.M.K., M.G.H.), Neurogenetic Unit (R.L., M.G.S., R.S., A.H., M.B.D.), Department of Molecular Neuroscience (E.M., M.G.H.), and Department of Clinical and Experimental Epilepsy (S.S., D.M.K.), UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London; Mitochondrial Research Group (P.C.), Newcastle University, Newcastle upon Tyne, UK; and Department of Neurology (G.M.), University of Milan, Italy.
-
- R. Labrum
- From MRC Centre for Neuromuscular Diseases (E.M., D.M.K., M.G.H.), Neurogenetic Unit (R.L., M.G.S., R.S., A.H., M.B.D.), Department of Molecular Neuroscience (E.M., M.G.H.), and Department of Clinical and Experimental Epilepsy (S.S., D.M.K.), UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London; Mitochondrial Research Group (P.C.), Newcastle University, Newcastle upon Tyne, UK; and Department of Neurology (G.M.), University of Milan, Italy.
-
- M. G. Sweeney
- From MRC Centre for Neuromuscular Diseases (E.M., D.M.K., M.G.H.), Neurogenetic Unit (R.L., M.G.S., R.S., A.H., M.B.D.), Department of Molecular Neuroscience (E.M., M.G.H.), and Department of Clinical and Experimental Epilepsy (S.S., D.M.K.), UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London; Mitochondrial Research Group (P.C.), Newcastle University, Newcastle upon Tyne, UK; and Department of Neurology (G.M.), University of Milan, Italy.
-
- R. Sud
- From MRC Centre for Neuromuscular Diseases (E.M., D.M.K., M.G.H.), Neurogenetic Unit (R.L., M.G.S., R.S., A.H., M.B.D.), Department of Molecular Neuroscience (E.M., M.G.H.), and Department of Clinical and Experimental Epilepsy (S.S., D.M.K.), UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London; Mitochondrial Research Group (P.C.), Newcastle University, Newcastle upon Tyne, UK; and Department of Neurology (G.M.), University of Milan, Italy.
-
- A. Haworth
- From MRC Centre for Neuromuscular Diseases (E.M., D.M.K., M.G.H.), Neurogenetic Unit (R.L., M.G.S., R.S., A.H., M.B.D.), Department of Molecular Neuroscience (E.M., M.G.H.), and Department of Clinical and Experimental Epilepsy (S.S., D.M.K.), UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London; Mitochondrial Research Group (P.C.), Newcastle University, Newcastle upon Tyne, UK; and Department of Neurology (G.M.), University of Milan, Italy.
-
- P. F. Chinnery
- From MRC Centre for Neuromuscular Diseases (E.M., D.M.K., M.G.H.), Neurogenetic Unit (R.L., M.G.S., R.S., A.H., M.B.D.), Department of Molecular Neuroscience (E.M., M.G.H.), and Department of Clinical and Experimental Epilepsy (S.S., D.M.K.), UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London; Mitochondrial Research Group (P.C.), Newcastle University, Newcastle upon Tyne, UK; and Department of Neurology (G.M.), University of Milan, Italy.
-
- G. Meola
- From MRC Centre for Neuromuscular Diseases (E.M., D.M.K., M.G.H.), Neurogenetic Unit (R.L., M.G.S., R.S., A.H., M.B.D.), Department of Molecular Neuroscience (E.M., M.G.H.), and Department of Clinical and Experimental Epilepsy (S.S., D.M.K.), UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London; Mitochondrial Research Group (P.C.), Newcastle University, Newcastle upon Tyne, UK; and Department of Neurology (G.M.), University of Milan, Italy.
-
- S. Schorge
- From MRC Centre for Neuromuscular Diseases (E.M., D.M.K., M.G.H.), Neurogenetic Unit (R.L., M.G.S., R.S., A.H., M.B.D.), Department of Molecular Neuroscience (E.M., M.G.H.), and Department of Clinical and Experimental Epilepsy (S.S., D.M.K.), UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London; Mitochondrial Research Group (P.C.), Newcastle University, Newcastle upon Tyne, UK; and Department of Neurology (G.M.), University of Milan, Italy.
-
- D. M. Kullmann
- From MRC Centre for Neuromuscular Diseases (E.M., D.M.K., M.G.H.), Neurogenetic Unit (R.L., M.G.S., R.S., A.H., M.B.D.), Department of Molecular Neuroscience (E.M., M.G.H.), and Department of Clinical and Experimental Epilepsy (S.S., D.M.K.), UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London; Mitochondrial Research Group (P.C.), Newcastle University, Newcastle upon Tyne, UK; and Department of Neurology (G.M.), University of Milan, Italy.
-
- M. B. Davis
- From MRC Centre for Neuromuscular Diseases (E.M., D.M.K., M.G.H.), Neurogenetic Unit (R.L., M.G.S., R.S., A.H., M.B.D.), Department of Molecular Neuroscience (E.M., M.G.H.), and Department of Clinical and Experimental Epilepsy (S.S., D.M.K.), UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London; Mitochondrial Research Group (P.C.), Newcastle University, Newcastle upon Tyne, UK; and Department of Neurology (G.M.), University of Milan, Italy.
-
- M. G. Hanna
- From MRC Centre for Neuromuscular Diseases (E.M., D.M.K., M.G.H.), Neurogenetic Unit (R.L., M.G.S., R.S., A.H., M.B.D.), Department of Molecular Neuroscience (E.M., M.G.H.), and Department of Clinical and Experimental Epilepsy (S.S., D.M.K.), UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London; Mitochondrial Research Group (P.C.), Newcastle University, Newcastle upon Tyne, UK; and Department of Neurology (G.M.), University of Milan, Italy.
収録刊行物
-
- Neurology
-
Neurology 72 (18), 1544-1547, 2009-05-05
Ovid Technologies (Wolters Kluwer Health)